Dodecylphosphocholine

CAS No. 29557-51-5

Dodecylphosphocholine( DPC | DDPPC | n-C12PC | Foscholine-12 | nC12PC | n C12PC )

Catalog No. M24215 CAS No. 29557-51-5

Dodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 27 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dodecylphosphocholine
  • Note
    Research use only, not for human use.
  • Brief Description
    Dodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
  • Description
    Dodecylphosphocholine is a substrate-type inhibitor of pancreas phospholipase A2. Dodecylphosphocholine is a detergent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DPC | DDPPC | n-C12PC | Foscholine-12 | nC12PC | n C12PC
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    pancreas phospholipase A2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    29557-51-5
  • Formula Weight
    351.47
  • Molecular Formula
    C17H38NO4P
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    CCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Goyal S, Qin H, Lim L, Song J. Insoluble protein characterization by circular dichroism (CD) spectroscopy and nuclear magnetic resonance (NMR). Methods Mol Biol. 2015;1258:371-85. doi: 10.1007/978-1-4939-2205-5_21. Review. PubMed PMID: 25447876.
molnova catalog
related products
  • JPH203 dihydrochlori...

    JPH203 dihydrochloride is a tyrosine analog, acts as a selective inhibitor of L-type amino acid transporter 1 (LAT1), and is used in cancer research.

  • ZLD1039

    ZLD1039 is a potent, orally bioavailable EZH2 (Enhancer of Zeste Homolog 2) inhibitor with high selectivity.

  • Astegolimab

    Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.